CP and COVID-19: While transient antiphospholipid antibody positivity has been observed in the acute phase of COVID-19, a causal relationship between this and thrombotic complications has yet to be confirmed.33 Most recipients in our study were LAC-positive at baseline and remained so after CP or placebo infusion, indicating that CP does not immediately alter phospholipid antibody status.